AI IntelligenceNov 12, 2026Primary Market
Article
Biomatter · $18M · Series A
Biomatter, a company specializing in custom enzyme design, raised $18M in an oversubscribed Series A funding round led by Astanor, with participation from existing investors UVC Partners and others.
AI-generated: summaries written by AI from the linked sources. How we use AI
AI-generatedSource: tech.eu
01
Source Brief
Biomatter, a company specializing in custom enzyme design, raised $18M in an oversubscribed Series A funding round led by Astanor, with participation from existing investors UVC Partners and others.
02